| 000 | 01020 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250514054546.0 | ||
| 264 | 0 | _c20030123 | |
| 008 | 200301s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/S0140-6736(03)12148-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSharma, Jagdish | |
| 245 | 0 | 0 |
_aDopamine agonists for Parkinson's disease. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJan 2003 |
||
| 300 |
_a84; author reply 84 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aDopamine Agonists _xtherapeutic use |
| 650 | 0 | 4 |
_aDyskinesias _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLevodopa _xtherapeutic use |
| 650 | 0 | 4 |
_aParkinson Disease _xcomplications |
| 700 | 1 | _aMacMahon, Doug | |
| 700 | 1 | _aStewart, David | |
| 773 | 0 |
_tLancet (London, England) _gvol. 361 _gno. 9351 _gp. 84; author reply 84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(03)12148-4 _zAvailable from publisher's website |
| 999 |
_c12320348 _d12320348 |
||